Insider Transactions in Q3 2023 at Arrowhead Pharmaceuticals, Inc. (ARWR)
Insider Transaction List (Q3 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 28
2023
|
Victoria Vakiener Director |
SELL
Open market or private sale
|
Direct |
1,550
-6.66%
|
$40,300
$26.33 P/Share
|
|
Sep 18
2023
|
Christopher Richard Anzalone Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
57,755
-0.76%
|
$1,617,140
$28.14 P/Share
|
|
Sep 18
2023
|
Christopher Richard Anzalone Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
57,755
+1.49%
|
$231,020
$4.75 P/Share
|
|
Jul 03
2023
|
Tracie Oliver Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
8,925
-12.66%
|
$312,375
$35.31 P/Share
|